All In Biotech

Free tool

FAERS Monitor: Vectical

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 022087 or its brand name (Vectical, Calcitriol). Reports on generic versions are filed under their own applications.

Reports

20,497

Serious

15,764

77% of reports

Hospitalization

8,660

Death reported

2,698

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • nausea1,485
  • diarrhoea1,212
  • off label use1,165
  • chronic kidney disease1,117
  • vomiting1,112
  • dyspnoea1,105
  • fatigue1,063
  • renal failure1,059
  • acute kidney injury975
  • death910
  • drug hypersensitivity883
  • drug ineffective831
  • abdominal pain791
  • headache784
  • asthenia769

Reports by year received

View as table
YearReports
2004179
2005245
2006171
2007190
2008282
2009390
2010395
2011413
2012543
2013567
2014561
2015896
20161,195
20171,385
20181,742
20192,334
20201,555
20211,454
20221,160
20231,215
20241,421
20251,212
2026992

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,033,662 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
chronic kidney diseaseSignal1,11715.314.414,744
renal failureSignal1,0598.27.86,719
acute kidney injurySignal9756.66.24,606
drug hypersensitivitySignal8834.74.42,579
abdominal painSignal7913.53.31,419
vomitingSignal1,1122.42.3954
astheniaSignal7692.12.0450
dyspnoeaSignal1,1052.01.9570
diarrhoea1,2121.91.8557
nausea1,4851.91.8686
fatigue1,0631.41.3126
off label use1,1651.41.3119
headache7841.31.250
death9101.11.06
drug ineffective8310.60.6171

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.